Page 236 - Read Online

Singh et al. Myocardial protection in cardiac transplantation

123. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for preconditioning in patients undergoing coronary artery bypass
treatment of acute myocardial infarction: an overview of randomized surgery: a single-centre randomised, double-blind, controlled trial.
placebo-controlled trials. Circulation 1997;96:1152-6. Lancet 2013;382:597-604.
124. Sun SC, Appleyard R, Masetti P, Byrne JG, Laurence RG, Marsh JD, 140. Hong DM, Lee EH, Kim HJ, Min JJ, Chin JH, Choi DK, Bahk JH,
Cohn LH. Improved recovery of heart transplants by combined use of Sim JY, Choi IC, Jeon Y. Does remote ischaemic preconditioning
oxygen-derived free radical scavengers and energy enhancement. J with postconditioning improve clinical outcomes of patients
Thorac Cardiovasc Surg 1992;104:830-7. undergoing cardiac surgery? Remote ischaemic preconditioning with
125. Pilati CF, Bosso FJ, Maron MB. Factors involved in left ventricular postconditioning outcome trial. Eur Heart J 2014;35:176-83.
dysfunction after massive sympathetic activation. Am J Physiol 141. Sachdeva J, Dai W, Gerczuk PZ, Kloner RA. Combined remote
1992;263:H784-91. perconditioning and postconditioning failed to attenuate infarct
126. Szabo G, Buhmann V, Bahrle S, Vahl CF, Hagl S. Brain death impairs size and contractile dysfunction in a rat model of coronary artery
coronary endothelial function. Transplantation 2002;73:1846-8. occlusion. J Cardiovasc Pharmacol Ther 2014;19:567-73.
127. Nicolas-Robin A, Amour J, Ibanez-Esteve C, Coriat P, Riou B, 142. Eitel I, Stiermaier T, Rommel KP, Fuernau G, Sandri M, Mangner
Langeron O. Effect of glucose-insulin-potassium in severe acute heart N, Linke A, Erbs S, Lurz P, Boudriot E, Mende M, Desch S, Schuler
failure after brain death. Crit Care Med 2008;36:2740-5. G, Thiele H. Cardioprotection by combined intrahospital remote
128. Heusch G, Schulz R, Rahimtoola SH. Myocardial hibernation: a ischaemic perconditioning and postconditioning in ST-elevation
delicate balance. Am J Physiol Heart Circ Physiol 2005;288:H984-99. myocardial infarction: the randomized lipsia conditioning trial. Eur
129. Stanley AW Jr, Moraski RE, Russell RO, Rogers WJ, Mantle JA, Heart J 2015;36:3049-57.
Kreisberg RA, McDaniel HG, Rackley CE. Effects of glucose-insulin- 143. Pichot S, Mewton N, Bejan-Angoulvant T, Roubille F, Rioufol G,
potassium on myocardial substrate availability and utilization in stable Giraud C, Boussaha I, Lairez O, Elbaz M, Piot C, Angoulvant D,
coronary artery disease. Studies on myocardial carbohydrate, lipid and Ovize M. Influence of cardiovascular risk factors on infarct size
oxygen arterial-coronary sinus differences in patients with coronary and interaction with mechanical ischaemic postconditioning in ST-
artery disease. Am J Cardiol 1975;36:929-37. elevation myocardial infarction. Open Heart 2015;2:e000175.
130. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH. Substrate 144. Moscarelli M, Angelini GD, Suleiman S, Fiorentino F, Punjabi PP.
metabolism as a determinant for postischemic functional recovery of Remote ischaemic preconditioning: is it a flag on the field? Perfusion
the heart. Am J Cardiol 1997;80: A3-10. 2015;30:438-47.
131. Cottin Y, Lhuillier I, Gilson L, Zeller M, Bonnet C, Toulouse C, 145. Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch
Louis P, Rochette L, Girard C, Wolf JE. Glucose insulin potassium G. Interference of propofol with signal transducer and activator of
infusion improves systolic function in patients with chronic ischaemic transcription 5 activation and cardioprotection by remote ischaemic
cardiomyopathy. Eur J Heart Fail 2002;4:181-4. preconditioning during coronary artery bypass grafting. J Thorac
132. Khoury VK, Haluska B, Prins J, Marwick TH. Effects of glucose- Cardiovasc Surg 2014;147:376-82.
insulin-potassium infusion on chronic ischaemic left ventricular 146. Kleinbongard P, Neuhäuser M, Thielmann M, Kottenberg E, Peters
dysfunction. Heart 2003;89:61-5. J, Jakob H, Heusch G. Confounders of cardioprotection by remote
133. Demircan S, Yazici M, Diraman E, Demircan G, Kilicaslan F, Durna ischaemic preconditioning in patients undergoing coronary artery
K, Acar Z, Eren Z. The effect of glucose-insulin-potassium treatment bypass grafting. Cardiology 2016;133:128-33.
on myocardial oxidative stress in patients with acute coronary 147. Hausenloy DJ, Boston-Griffiths EA, Yellon DM. Cyclosporin A and
syndromes undergoing percutaneous coronary intervention. Coron cardioprotection: from investigative tool to therapeutic agent. Br J
Artery Dis 2008;19:99-104. Pharmacol 2012;165:1235-45.
134. Kalay N, Ozdogru I, Gul A, Yucel Y, Cetinkaya Y, Inanc MT, Dogan 148. Hausenloy DJ, Kunst G, Boston-Griffiths E, Kolvekar S, Chaubey
A, Kaya MG, Eryol NK. Effects of intermittent and long-term glucose- S, John L, Desai J, Yellon D. The effect of cyclosporin-A on peri-
insulin-potassium infusion in patients with systolic heart failure. Exp operative myocardial injury in adult patients undergoing coronary
Clin Cardiol 2008;13:85-8. artery bypass graft surgery: a randomised controlled clinical trial. Heart
135. Klein LJ, van Campen CM, Sieswerda GT, Kamp O, Visser FC. 2014;100:544-9.
Effects of high-dose insulin infusion on left ventricular function in 149. Iyer A, Gao L, Doyle A, Rao P, Jayewardene D, Wan B, Kumarasinghe
normal subjects. Neth Heart J 2010;18:183-9. G, Jabbour A, Hicks M, Jansz PC, Feneley MP, Harvey RP, Graham
136. Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe RM, Dhital KK, Macdonald PS. Increasing the tolerance of DCD
C, Coburn M, Schaelte G, Böning A, Niemann B, Roesner J, Kletzin hearts to warm ischemia by pharmacological postconditioning. Am J
F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes Transplant 2014;14:1744-52.
IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, 150. Watson AJ, Gao L, Sun L, Tsun J, Jabbour A, Ru Qiu M, Jansz PC,
Meyer-Treschan T, Kienbaum P, Heringlake M, Schön J, Sander Hicks M, Macdonald PS. Enhanced preservation of the rat heart after
M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, prolonged hypothermic ischemia with erythropoietin-supplemented
Hasenclever D, Zacharowski K; RIPHeart Study Collaborators. Celsior solution. J Heart Lung Transplant 2013;32:633-40.
A multicenter trial of remote ischaemic preconditioning for heart 151. Trahanas JM, Witer LJ, Alghanem F, Bryner BS, Iyengar A, Hirschl
surgery. N Engl J Med 2015;373:1397-407. JR, Hoenerhoff MJ, Potkay JA, Bartlett RH, Rojas-Pena A, Owens GE,
137. Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar Bocks ML. Achieving 12 hour normothermic ex situ heart perfusion: an
S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson experience of 40 porcine hearts. ASAIO J 2016;62:470-6.
S, Xenou M, Clayton T, Yellon DM; ERICCA Trial Investigators. 152. Hing AJ, Watson A, Hicks M, Gao L, Faddy SC, McMahon AC,
Remote ischaemic preconditioning and outcomes of cardiac surgery. Kesteven SH, Wilson MK, Jansz P, Feneley MP, Macdonald PS.
N Engl J Med 2015;373:1408-17. Combining cariporide with glyceryl trinitrate optimizes cardiac
138. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional preservation during porcine heart transplantation. Am J Transplant
ischaemic ‘preconditioning’ protects remote virgin myocardium from 2009;9:2048-56.
subsequent sustained coronary occlusion. Circulation 1993;87:893-9. 153. Gao L, Tsun J, Sun L, Kwan J, Watson A, Macdonald PS, Hicks M.
139. Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Critical role of the STAT3 pathway in the cardioprotective efficacy
Pasa S, Price V, Tsagakis K, Neuhäuser M, Peters J, Jakob H, Heusch of zoniporide in a model of myocardial preservation - the rat isolated
G. Cardioprotective and prognostic effects of remote ischaemic working heart. Br J Pharmacol 2011;162:633-47.
Vessel Plus ¦ Volume 1 ¦ December 28, 2017 229